Syncytiotrophoblast Markers Are Downregulated in Placentas from Idiopathic Stillbirths.
cytotrophoblast
idiopathic stillbirth
placenta
syncytiotrophoblast
transcriptome
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
09 May 2024
09 May 2024
Historique:
received:
01
04
2024
revised:
03
05
2024
accepted:
07
05
2024
medline:
25
5
2024
pubmed:
25
5
2024
entrez:
25
5
2024
Statut:
epublish
Résumé
The trophoblast cells are responsible for the transfer of nutrients between the mother and the foetus and play a major role in placental endocrine function by producing and releasing large amounts of hormones and growth factors. Syncytiotrophoblast cells (STB), formed by the fusion of mononuclear cytotrophoblasts (CTB), constitute the interface between the foetus and the mother and are essential for all of these functions. We performed transcriptome analysis of human placental samples from two control groups-live births (LB), and stillbirths (SB) with a clinically recognised cause-and from our study group, idiopathic stillbirths (iSB). We identified 1172 DEGs in iSB, when comparing with the LB group; however, when we compared iSB with the SB group, only 15 and 12 genes were down- and upregulated in iSB, respectively. An assessment of these DEGs identified 15 commonly downregulated genes in iSB. Among these, several syncytiotrophoblast markers, like genes from the
Identifiants
pubmed: 38791219
pii: ijms25105180
doi: 10.3390/ijms25105180
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundação para a Ciência e Tecnologia
ID : EXPL/MED-GEN/1261/2021
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/147440/2019
Organisme : Fundação para a Ciência e Tecnologia
ID : CEECIND/00371/2017
Organisme : Dutch Organization for Health Research and Development
ID : ZonMW PSIDER-2021-10250022120001
Organisme : Novo Nordisk Foundation
ID : reNEW NNF21CC0073729